ClinVar Miner

Submissions for variant NM_000089.4(COL1A2):c.2035G>A (p.Gly679Ser)

dbSNP: rs1584325552
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 2
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Mendelics RCV000987926 SCV001137420 likely pathogenic Ehlers-Danlos syndrome, classic type 2019-05-28 criteria provided, single submitter clinical testing
Neuberg Centre For Genomic Medicine, NCGM RCV001823173 SCV002072978 likely pathogenic Osteogenesis imperfecta, perinatal lethal criteria provided, single submitter clinical testing The missense variant p.G679S in COL1A2 (NM_000089.4) has been submitted to ClinVar as Likely Pathogenic but no details are available for independent assesment. The variant is not reported in literature in affected individuals. The p.G679S variant is novel (not in any individuals) in gnomAD Exomes and is novel (not in any individuals) in 1000 Genomes. The variant affects a glycine residue within the collagen triple helix. Glycine residues within the triple helix are important and their substitution is usually associated with disease.The p.G679S missense variant is predicted to be damaging by both SIFT and PolyPhen2. The glycine residue at codon 679 of COL1A2 is conserved in all mammalian species. The nucleotide c.2035 in COL1A2 is predicted conserved by GERP++ and PhyloP across 100 vertebrates. For these reasons, this variant has been classified as Likely Pathogenic

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.